328P Time toxicity (TT) associated with first-line treatment (1L) in patients (pts) with advanced biliary tract cancer (aBTC)Naohiro Okano, Mitesh J. Borad, Pedro Luiz Serrano Usón et al.|Annals of Oncology|2025Cited by 0
Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without DurvalumabN. Okano, Mitesh J. Borad, Angelo Pirozzi et al.|JCO oncology advances.|2026Cited by 0